Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

B-239 Characterization and Frequency of Cytogenetic Findings in Patients with Chronic Myeloid Leukemia

View through CrossRef
Abstract Background Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder that accounts for 15% to 20% of leukemias. It is characterized by the expansion of hematopoietic progenitor cells, leukocytosis with left shift, splenomegaly and the presence of the Philadelphia chromosome (Ph), resulting from a translocation between chromosomes 9q34 and 22q11, which generates the BCR-ABL gene. This gene leads to the production of the BCR-ABL protein, which stimulates cell proliferation and inhibits apoptosis, reinforcing the importance of this molecular alteration in the study and treatment of the disease. The Ph chromosome is identified in the chronic phase of CML. As the disease progresses, other chromosomal alterations may appear. The aim of this study was to evaluate the main cytogenetic findings in patients diagnosed or under investigation for CML, with a focus on identifying the most frequent chromosomal alterations. Methods A total of 237 karyotypes were analyzed from patients aged between 8 and 90 years, with suspected or confirmed CML, between July 2021 and October 2024. Results Of the 237 samples analyzed, 53.6% came from male patients and the most prevalent age group in males was 51 to 60 years (26.2%), while in females the 41 to 50 age group was predominated (28.5%). Among the patients evaluated, 36.7% (87/237) had normal karyotype results. Of these, 43.8% (38/87) were under investigation for CML, but the hypothesis was ruled out, 5.7% were not diagnosed due to a lack of clinical information and complementary tests, and 50.5% of the patients were undergoing treatment, which may have influenced the normal karyotype. Among the patients undergoing treatment, the most prevalent age group was 61 to 70 years, representing 34.1% of the cases. In addition, 3.45% of the patients were aged between 11 and 18. The presence of Philadelphia chromosome was detected in 58.2% (138/237) of patients. The most affected age group was 51 to 60 years, corresponding to 22.5% of cases, while 5.8% were aged between 11 and 17. The variant Philadelphia chromosome was identified in 2.95% (7/237) of patients. The other chromosomes detected were 3, 6, 9, 12, 14, 17 and 21, with the translocation involving chromosome 9 occurring in two cases. The other translocations were identified only once. The most prevalent age was 41 to 50 years, representing 42.85% of the cases. Other five chromosomal alterations were detected, such as: (i) Trisomy of chromosome 8: detected in 0.8% (2/237) of patients, one of whom also had Philadelphia chromosome; (ii) Monosomy of chromosome 7 was identified in 0.4% of patients; (iii) Intra-chromosomal translocation on chromosome 3 was observed in 0.4% of patients, involving two regions of chromosome 3; (iv) reciprocal translocation between chromosomes 5 and 15 was present in 0.42% of the patients. Conclusion The Philadelphia chromosome is a robust biomarker for CML, standing out in the diagnosis and monitoring of the disease. The use of cytogenetic techniques is essential for identifying chromosomal alterations, allowing for identification and a personalized therapeutic approach, optimizing the effectiveness of the clinical management of these patients.
Title: B-239 Characterization and Frequency of Cytogenetic Findings in Patients with Chronic Myeloid Leukemia
Description:
Abstract Background Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder that accounts for 15% to 20% of leukemias.
It is characterized by the expansion of hematopoietic progenitor cells, leukocytosis with left shift, splenomegaly and the presence of the Philadelphia chromosome (Ph), resulting from a translocation between chromosomes 9q34 and 22q11, which generates the BCR-ABL gene.
This gene leads to the production of the BCR-ABL protein, which stimulates cell proliferation and inhibits apoptosis, reinforcing the importance of this molecular alteration in the study and treatment of the disease.
The Ph chromosome is identified in the chronic phase of CML.
As the disease progresses, other chromosomal alterations may appear.
The aim of this study was to evaluate the main cytogenetic findings in patients diagnosed or under investigation for CML, with a focus on identifying the most frequent chromosomal alterations.
Methods A total of 237 karyotypes were analyzed from patients aged between 8 and 90 years, with suspected or confirmed CML, between July 2021 and October 2024.
Results Of the 237 samples analyzed, 53.
6% came from male patients and the most prevalent age group in males was 51 to 60 years (26.
2%), while in females the 41 to 50 age group was predominated (28.
5%).
Among the patients evaluated, 36.
7% (87/237) had normal karyotype results.
Of these, 43.
8% (38/87) were under investigation for CML, but the hypothesis was ruled out, 5.
7% were not diagnosed due to a lack of clinical information and complementary tests, and 50.
5% of the patients were undergoing treatment, which may have influenced the normal karyotype.
Among the patients undergoing treatment, the most prevalent age group was 61 to 70 years, representing 34.
1% of the cases.
In addition, 3.
45% of the patients were aged between 11 and 18.
The presence of Philadelphia chromosome was detected in 58.
2% (138/237) of patients.
The most affected age group was 51 to 60 years, corresponding to 22.
5% of cases, while 5.
8% were aged between 11 and 17.
The variant Philadelphia chromosome was identified in 2.
95% (7/237) of patients.
The other chromosomes detected were 3, 6, 9, 12, 14, 17 and 21, with the translocation involving chromosome 9 occurring in two cases.
The other translocations were identified only once.
The most prevalent age was 41 to 50 years, representing 42.
85% of the cases.
Other five chromosomal alterations were detected, such as: (i) Trisomy of chromosome 8: detected in 0.
8% (2/237) of patients, one of whom also had Philadelphia chromosome; (ii) Monosomy of chromosome 7 was identified in 0.
4% of patients; (iii) Intra-chromosomal translocation on chromosome 3 was observed in 0.
4% of patients, involving two regions of chromosome 3; (iv) reciprocal translocation between chromosomes 5 and 15 was present in 0.
42% of the patients.
Conclusion The Philadelphia chromosome is a robust biomarker for CML, standing out in the diagnosis and monitoring of the disease.
The use of cytogenetic techniques is essential for identifying chromosomal alterations, allowing for identification and a personalized therapeutic approach, optimizing the effectiveness of the clinical management of these patients.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Activation Of EphrinB2/EphB4 Influences Myeloid Leukemia Cell Migration and Invasion
Activation Of EphrinB2/EphB4 Influences Myeloid Leukemia Cell Migration and Invasion
Abstract Eph receptors and ephrin ligands are cell-surface molecules capable of bidirectional signaling that control cell-cell interactions, migration and invasion. ...
STAT3 Mutations in Large Granular Lymphocytic Leukemia
STAT3 Mutations in Large Granular Lymphocytic Leukemia
Abstract Abstract 1606 Introduction: Large granular lymphocytic leukemia (LGL leukemia) is a rare lymphoprolifera...
Cytogenetic profile of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia in Northern Pakistan
Cytogenetic profile of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia in Northern Pakistan
Objective: To determine the frequencies of different cytogenetic abnormalities in patients of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia in Northern Pakistan. Methods...
ROR1 Expression Accelerates Leukemia Development in RORxTCL1 Transgenic Mice,
ROR1 Expression Accelerates Leukemia Development in RORxTCL1 Transgenic Mice,
Abstract Abstract 3905 ROR1 is a receptor tyrosine kinase-like orphan receptor and an oncofetal protein that is expressed on chronic lymphocytic leuke...

Back to Top